Abstract
Background
Esophagectomy is a fundamental step to achieve long-term disease-free survival in esophageal cancer. While various approaches have been described, there is no consensus on the single best technique to optimize operative and oncologic outcomes. We aim to report the modern experience with laparoscopic transhiatal esophagectomy (LTHE) for invasive adenocarcinoma.
Methods
We reviewed all patients who underwent LTHE with extended lymph node dissection for distal esophageal adenocarcinoma (EAC) at our institution between 2007 and 2016. Pre-operative characteristics, operative details, postoperative complications, and long-term outcomes were tracked by review of the electronic medical record and patient surveys. Survival rates were calculated with Kaplan-Meier curves.
Results
Eighty-two EAC patients underwent LTHE during the study period (84% male, mean age 65, mean BMI 27.8, large). Most patients were clinical stage III (42.7%) and 68.3% had received neoadjuvant chemoradiation (nCRT). Laparoscopy was successful in 93.9%, with five cases requiring conversion to open (6.1%). The median lymph node harvest was 19. Overall complication rate (major and minor) was 45.5% and ninety-day mortality was 4%. Overall 5-year survival was 52% (77% for stage 1, 57% for stage 2, 37% for stage 3).
Conclusions
Laparoscopic transhiatal esophagectomy has an important role in current esophageal cancer treatment and can be performed with curative intent in patients with distal esophageal tumors. In addition to the well-known advantages of laparoscopy, the increased mediastinal visibility and a modern focus on oncologic principles seem to have a positive impact on cancer survival compared to the open transhiatal approach.
Similar content being viewed by others
References
Namm JP, Posner MC. Transhiatal Esophagectomy for Esophageal Cancer. J Laparoendosc Adv Surg Tech. 2016;26(10):752–757.
Borggreve AS, Kingma BF, Domrachev SA, et al. Surgical treatment of esophageal cancer in the era of multimodality management. Ann NY Acad Sci. 2018:1–18.
Dunst CM, Swanström LL. Minimally invasive esophagectomy. J Gastrointest Surg. 2010;14(SUPPL.1):108–114.
Trends C, Learned L, Orringer MB, et al. Two Thousand Transhiatal Esophagectomies. Ann Surg. 2007;246(3):363–374.
Orringer MB, Marshall B, Iannettoni MD. Transhiatal Esophagectomy : Clinical Experience and Refinements. Ann Surg. 1999;230(3):392–403.
DePaula AL, Hashiba K, Ferreira EA, de Paula RA GE. Laparoscopic transhiatal esophagectomy with esophagogastroplasty. Surg Laparosc Endosc. 1995;5(1):1–5.
Swantröm LL, Hansen P. Laparoscopic Total Esophagectomy. Arch Surg. 1997;132(9):943–7; discussion 947-9.
Lee Y, Min SH, Park KB, Park YS, Ahn SH, Park DJ, Kim HH.Long-term Outcomes of Laparoscopic Versus Open TranshiatalApproach for the Treatment of Esophagogastric Junction Cancer. J Gastric Cancer. 2019 Mar;19(1):62–71.
Puntambekar S, Gauba Y, Chitale M, et al. Evaluation of 5-year results of laparoscopic transhiataloesophagectomy as a single-centre experience. J Minim Access Surg. 2018 Aug 7. doi: https://doi.org/10.4103/jmas.JMAS_81_18. [Epub ahead of print]
Maas KW, Biere SS, Scheepers JJ, Gisbertz SS, van-der-Peet DL, Cuesta MA. Laparoscopic versus open transhiatal esophagectomy for distal and junction cancer. Rev Esp Enferm Dig. 2012 Apr;104(4):197–202.
Hulscher, J.B.F., J.W. van Sandick, A.G.E.M. de Boer et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med. 2002;347(21):1662–1669.
Montenovo MI, Chambers K, Pellegrini CA, Oelschlager BK. Outcomes of laparoscopic-assisted transhiatal esophagectomy for adenocarcinoma of the esophagus and esophago-gastric junction. Dis of the Esophagus. 2011;24:430–436.
Cash JC, Zehetner J, Hedayati B, Mason RJ, Lipham JC. Outcomes following laparoscopic transhiatal esophagectomy for esophageal cancer. Surg Endosc. 2014;28:492–499.
Orringer MB. Transhiatal Esophagectomy : How I Teach It. Ann Thorac Surg. 2016;102(5):1432–1437.
Rice TW, Blackstone EH, Rusch VW. 7th Edition of the AJCC Cancer Staging Manual: Esophagus and Esophagogastric Junction. Ann Surg Oncol. 2010;17(7):1721–1724.
Siewert J R SHJ. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg. 1998;85:1457–1459.
Dindo D, Demartines N, Clavien P. Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey. Ann Surg. 2004 Aug;240(2):205–213.
Eypasch E, Williams JI, Wood-Dauphinee S, et al. Gastrointestinal Quality of Life Index: development, validation and application of a new instrument. Br J Surg. 1995;82(2):216–222.
Haverkamp L, Seesing MFJ, Ruurda JP, Boone J, Hillegersberg R. Worldwide trends in surgical techniques in the treatment of esophageal and gastroesophageal junction cancer. Dis of the Esophagus. 2017;30:1–7.
Gurusamy KS, Pallari E, Midya S, Mughal M. Laparoscopic versus open transhiatal oesophagectomy for oesophageal cancer. Cochrane Database Syst Rev. 2016 Mar 31;3:CD011390. doi: https://doi.org/10.1002/14651858.CD011390.pub2.
Omloo JM, Lagarde SM, Hulscher JB, Reitsma JB, Fockens P, van Dekken H, Ten Kate FJ, Obertop H, Tilanus HW, van Lanschot JJ. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg. 2007 Dec;246(6):992–1000.
American Cancer Society's (ACS) publication, Cancer Facts & Figures 2019, and the ACS website (January 2019).
van Hagen P, Hulshof MC, van Lanschot JJ, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012 May 31;366(22):2074–84.
Njei B, Mccarty TR, Birk JW. Trends in esophageal cancer survival in United States adults from 1973 to 2009: a SEER database analysis. J Gastroenterol Hepatol. 2016;31(6):1141–1146.
Hagen JA, DeMeester SR, Peters JH, Chandrasoma P, DeMeester TR. Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies. Ann Surg. 2001 Oct;234(4):520–30; discussion 530-1.
Leers JM, DeMeester SR, Chan N, et al. Clinical characteristics, biologic behavior, and survival after esophagectomy are similar for adenocarcinoma of the gastroesophageal junction and the distal esophagus. J Thorac Cardiovasc Surg. 2009 Sep;138(3):594–602; discussion 601-2.
Rice TW, Ishwaran H, Hofstetter WL, et al. Esophageal Cancer: Associations With (pN+) Lymph Node Metastases. Ann Surg. 2017 Jan;265(1):122–129.
Dudash MJ, Slipak S, Dove J, et al. Lymph Node Harvest as a Measure of Quality and Effect on Overall Survival in Esophageal Cancer: A National Cancer Database Assessment. Am Surg. 2019 Feb 1;85(2):201–205.
Yang TH, He YZ, Wang ZQ. Transthoracic vs transhiatal surgery for cancer of the esophagogastric junction: a meta-analysis. World J Gastroenterol. 2014 Aug 7;20(29):10183–92.
Davies AR, Sandhu H, Pillai A, et al. Surgical resection strategy and the influence of radicality on outcomes in oesophageal cancer. Br J Surg. 2014 Apr;101(5):511–7.
Altorki N, Skinner D. Should en bloc esophagectomy be the standard of care for esophageal carcinoma? Ann Surg. 2001 Nov;234(5):581–7.
Lagergren J, Mattsson F, Zylstra J, et al. Extent of Lymphadenectomy and Prognosis After Esophageal Cancer Surgery. JAMA Surg. 2016 Jan;151(1):32–9.
van der Schaaf M, Johar A, Wijnhoven B, Lagergren P, Lagergren J. Extent of lymph node removal during esophageal cancer surgery and survival. J Natl Cancer Inst. 2015 Mar 5;107(5).
Hu W, Liang Y, Zhang S, Hu Y, Liu J. The significance of subcarinal dissection in esophageal cancer surgery. Asia Pac J Clin Oncol. 2014 Jun;10(2):183–9. doi: https://doi.org/10.1111/ajco.12095. Epub 2013 Aug 5
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Haisley, K.R., Abdelmoaty, W.F. & Dunst, C.M. Laparoscopic Transhiatal Esophagectomy for Invasive Esophageal Adenocarcinoma. J Gastrointest Surg 25, 9–15 (2021). https://doi.org/10.1007/s11605-019-04506-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-019-04506-4